This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A practical, step-by-step look at your first crypto choice, wallet setup, and safe entry tactics for beginners.
25,128 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Oil prices rebounded today, lifting energy stocks. ExxonMobil led gains as the market priced in stronger cash flow, s...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Investors are asking what's going with Uber stock as the company diversifies beyond ridesharing. This guide breaks do...
ExxonMobil and Chevron post contrasting Q1 results as oil prices rebound, highlighting divergent paths to dividends. ...
When a major institutional investor trims a fund like COMT, the move can ripple through risk, liquidity, and prices. ...
This article breaks down APi Group's Q1 2026 earnings call, translating the numbers into actionable takeaways for inv...
PBDC, a focused BDC ETF, slashed its April 2026 payout by about 14% to $0.71273 per share. With shares near $27 and a...
Oil hovered around $95 per barrel on June 11, 2026, as traders weigh supply discipline and demand trends. The move co...
The early 2027 social security outlook points to a higher potential COLA, but gains may still lag behind rising livin...
From chart-topping beats to smart money moves, this article dives into personal finance lessons inspired by Keith, th...
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...